Trademark: 86357017
Word
NCOUNTER SPRINT
Status
Registered
Status Code
702
Status Date
Wednesday, June 29, 2022
Serial Number
86357017
Registration Number
5124745
Registration Date
Tuesday, January 17, 2017
Mark Type
4000
Filing Date
Monday, August 4, 2014
Published for Opposition
Tuesday, September 22, 2015

Trademark Owner History
NanoString Technologies, Inc. - Original Registrant

Classifications
9 computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadable
5 diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care, namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
1 diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors, namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
ENCOUNTER SPRINT

Trademark Events
Jun 29, 2022
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jun 29, 2022
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 29, 2022
Case Assigned To Post Registration Paralegal
Jan 25, 2022
Teas Section 8 & 15 Received
Jan 17, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 18, 2020
Assignment Of Ownership Not Updated Automatically
Jan 17, 2017
Registered-Principal Register
Dec 13, 2016
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 12, 2016
Allowed Principal Register - Sou Accepted
Nov 18, 2016
Notice Of Approval Of Extension Request E-Mailed
Nov 17, 2016
Statement Of Use Processing Complete
Nov 7, 2016
Use Amendment Filed
Nov 17, 2016
Sou Extension 2 Granted
Nov 7, 2016
Sou Extension 2 Filed
Nov 7, 2016
Teas Extension Received
Nov 7, 2016
Teas Statement Of Use Received
Jun 10, 2016
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2016
Sou Extension 1 Granted
May 13, 2016
Sou Extension 1 Filed
Jun 9, 2016
Case Assigned To Intent To Use Paralegal
May 13, 2016
Teas Extension Received
Nov 17, 2015
Noa E-Mailed - Sou Required From Applicant
Sep 22, 2015
Official Gazette Publication Confirmation E-Mailed
Sep 22, 2015
Published For Opposition
Sep 2, 2015
Notification Of Notice Of Publication E-Mailed
Aug 19, 2015
Law Office Publication Review Completed
Aug 12, 2015
Assigned To Lie
Jul 29, 2015
Approved For Pub - Principal Register
Jul 12, 2015
Notice Of Revival - E-Mailed
Jul 11, 2015
Teas/Email Correspondence Entered
Jul 10, 2015
Correspondence Received In Law Office
Jul 10, 2015
Teas Response To Office Action Received
Jul 10, 2015
Petition To Revive-Granted
Jul 10, 2015
Teas Petition To Revive Received
Jun 22, 2015
Abandonment Notice Mailed - Failure To Respond
Jun 22, 2015
Abandonment - Failure To Respond Or Late Response
Nov 24, 2014
Notification Of Non-Final Action E-Mailed
Nov 24, 2014
Non-Final Action E-Mailed
Nov 24, 2014
Non-Final Action Written
Nov 17, 2014
Assigned To Examiner
Aug 14, 2014
Notice Of Pseudo Mark E-Mailed
Aug 13, 2014
New Application Office Supplied Data Entered In Tram
Aug 7, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24